Further insight into the impact of the NLA guideline, ESC guideline, and AACE/ACE guideline on LDL-cholesterol target achievement: Time to rethink the strategy?

Int J Cardiol. 2018 Nov 15:271:347. doi: 10.1016/j.ijcard.2018.05.005. Epub 2018 May 3.

Authors

Haoyu Wang¹, Yingxian Sun²

Affiliations

¹ Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang 110001, China.
² Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang 110001, China. Electronic address: syxcmu1h@163.com.

PMID: 29735422
DOI: 10.1016/j.ijcard.2018.05.005

No abstract available

Keywords: Cardiovascular disease; Dyslipidemia; LDL-C target; Risk assessment; Stains; Treatment goal.

Publication types

Letter
Comment

MeSH terms

Cholesterol, LDL*
Dyslipidemias*
Humans
Hypolipidemic Agents
Practice Guidelines as Topic
Risk Factors

Substances

Cholesterol, LDL
Hypolipidemic Agents